Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison

PURPOSE: Both brodalumab and guselkumab improve skin clearance in patients with moderate-to-severe plaque psoriasis after inadequate response to ustekinumab. In the absence of a direct head-to-head comparison, the relative efficacy of brodalumab and guselkumab in non-responders to ustekinumab were c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hampton, Philip, Borg, Emma, Hansen, Jes Birger, Augustin, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575184/
https://www.ncbi.nlm.nih.gov/pubmed/34765537
http://dx.doi.org/10.2147/PTT.S326121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575184/
https://www.ncbi.nlm.nih.gov/pubmed/34765537
http://dx.doi.org/10.2147/PTT.S326121

Ejemplares similares